Curcumae Rhizoma: An anti-cancer traditional Chinese medicine
- PMID: 40734908
- PMCID: PMC12301925
- DOI: 10.1016/j.chmed.2025.04.006
Curcumae Rhizoma: An anti-cancer traditional Chinese medicine
Abstract
Curcumae Rhizoma, derived from the rhizome of Curcuma phaeocaulis, Curcuma kwangsiensis and Curcuma wenyujin, was called Ezhu in China. In the past, Curcumae Rhizoma extracts were obtained through water decoction or alternative methods, which showed significant anti-cancer effects. However, the mixed extracts contain various compound components of Curcumae Rhizoma, leading to an ambiguous mechanism of action for Curcumae Rhizoma extracts anti-cancer. Contemporary researchers have extracted the chemical components of Curcumae Rhizoma separately for experimental verification of its active ingredients in the anti-cancer field. Numerous studies demonstrated that curcumol, germacrone, β-elemene, and curcumin in Curcumae Rhizoma extracts have significant governing effects in anti-cancer activities. Pharmacological studies have shown that Curcumae Rhizoma suppresses cancer cell proliferation, invasion, and migration, triggering apoptosis and regulating cellular autophagy to achieve anticancer effects. Here, we summarized the research progress of Curcumae Rhizoma on anti-cancer effects from 2013 to 2022, aiming to explore the deeper molecular mechanisms of Curcumae Rhizoma's active components in cancer treatment.
Keywords: Curcumae Rhizoma; Ezhu; cancer; curcumin; curcumol; germacrone; traditional Chinese medicine; β-elemene.
© 2025 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Abbas H., El-Feky Y.A., Al-Sawahli M.M., El-Deeb N.M., El-Nassan H.B., Zewail M. Development and optimization of curcumin analog nano-bilosomes using 21.31 full factorial design for anti-tumor profiles improvement in human hepatocellular carcinoma: In-vitro evaluation, in-vivo safety assay. Drug Delivery. 2022;29(1):714–727. - PMC - PubMed
-
- Barrero A.F., Herrador M.M., Arteaga P., Catalan J.V. Germacrone: Occurrence, synthesis, chemical transformations and biological properties. Natural Product Communications. 2008;3(4)
-
- Basniwal R.K., Khosla R., Jain N. Improving the anticancer activity of curcumin using nanocurcumin dispersion in water. Nutrition and Cancer. 2014;66(6):1015–1022. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
